Saturday, 15 August 2020

Esketamine: Now FDA Approved as a Treatment for Acute Depression

As of this month, the U.S. Food and Drug Administration (FDA) has approved the use of esketamine nasal spray as an adjunctive treatment modality for a novel application in major...

from Psych Central Professional https://ift.tt/31YHApi
via https://ifttt.com/ IFTTT

No comments:

Post a Comment